Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
60 participants
INTERVENTIONAL
2010-01-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Lidocaine/Dexamethasone on the Success of IANB
NCT03531970
Effect of Sodium Bicarbonate Buffered Lidocaine on the Success of IAN Block of Teeth With Irreversible Pulpitis
NCT02226913
How Successful is Supplemental Intraseptal Anaesthesia in Patients With Mandibular Teeth Extraction or Irreversible Pulpitis
NCT03880409
Assessment of Local Anaesthesia Effectiveness in Symptomatic Irreversible Pulpitis
NCT06862570
Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay
NCT01954368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine with Epinephrine+ Normal saline
Lidocaine with Epinephrine+ Normal saline
PDL injection of 0/4 ml of lidocaine %2 with epinephrine,and Normal saline
Lidocaine with Epinephrine + sufentanil
Lidocaine with Epinephrine + sufentanil
PDL injection of 0/4 ml lidocaine with epinephrine and0/4 ml sufentanil ( 0/04 μg)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine with Epinephrine+ Normal saline
PDL injection of 0/4 ml of lidocaine %2 with epinephrine,and Normal saline
Lidocaine with Epinephrine + sufentanil
PDL injection of 0/4 ml lidocaine with epinephrine and0/4 ml sufentanil ( 0/04 μg)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy (ASA I, II)
* patients with first or second mandibular molars who need endodontic treatment
* vital tooth without a history of past endodontic treatment
* patients with clinical evidence of irreversible Pulpits with moderate to severe pain
* patients who signed consent form
* patients numbness at the lateral edge of the lips after inferior alveolar injection (INA) and those with positive respond to maximum output of pulp tester after INA.
Exclusion Criteria
* necrotic tooth
* patients with allergy or contraindication toward non-opioid or opioid painkillers such as aspirin or NSAIDs
* Patients who have taken opioid or non opioid or steroid pain killers, antidepressants or sedative drugs in the past 48 hours
* patient with infectious diseases
* patient with moderate to sever periodontal disease
* those without numbness at the lateral edge of the lips after inferior alveolar injection (INA), and those do not respond to maximum output of pulp tester after INA.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Islamic Azad University, Sanandaj
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mandana Abedi Tari
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mandana Abedi Tari, Dentist
Role: PRINCIPAL_INVESTIGATOR
Dental School of Azad University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dental School of Azad University
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRCT201110137790N1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.